BENITIONSClinical Trial Intelligence

Diabetes Disparities: Texting to Extend Treatment (DD-TXT)

N/A Completed NCT04227379

ConditionDiabetes Mellitus, Type 2
PhaseN/A
SponsorVA Office of Research and Development
StatusCompleted
Enrollment366 participants
InterventionsIntervention 1- DSMS+, Comparison - DSMS
Start dateJan 30, 2023
Completion dateApr 30, 2025
Results postedJun 1, 2026

Summary

One way to help Veterans improve their diabetes control is through the use of technology to help provide information, motivation, and reminders necessary to support diabetes self-management. The study will seek input from diverse groups of Veterans living with diabetes to help develop a new customizable, interactive texting intervention that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie for Veterans", a VA texting system for self-management support. Patients will be randomized to receive a once-daily standard diabetes self-management texting intervention called DSMS based on standard diabetes self-management education content or a customizable, patient-centered diabetes self-management support intervention with additional features called DSMS Plus (DSMS+) in order to test the comparative effectiveness of these two texting interventions.

Change in HbA1c Percent Time in Control

pre-enrollment, 6 month follow up · percent (%) of time in control

DSMS23.41 ± 34.96 percent (%) of time in control
DSMS+ (DSMS Plus)21.61 ± 40.55 percent (%) of time in control
p-value.6519
Mean Difference (Net)1.80 (95% CI -6.05–9.65)

Change in HbA1c

pre-enrollment, 6 month follow-up · Percentage of glycosylated hemoglobin

DSMS-0.36 ± 1.37 Percentage of glycosylated hemoglobin
DSMS+ (DSMS Plus)-0.40 ± 1.29 Percentage of glycosylated hemoglobin
p-value.7552
Mean Difference (Net).05 (95% CI -.25–.34)

Open in BENITIONS View on ClinicalTrials.gov

Other trials for this condition

All trials

This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.